Senators again point to AbbVie as a poster child for reform. Only this time Dems are targeting a low, low tax rate - Endpoints News

In the first 4 years after AbbVie split away from Abbott with its big cash cow Humira in tow back in 2013, the pharma giant paid an effective tax rate that ranged anywhere from 20% to 25%. But after dipping a bit in 2017, their tax rate plunged into single

ALS is a debilitating, universally fatal disease. As motor neurons die, patients lose their abilities to walk, cut their own food, swallow and eventually, breathe. Most patients die within three to f… [+702 chars]

full article...